Journal article
Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial
- Abstract:
-
To determine the proportion of patients with psoriatic arthritis in the Adalimumab Effectiveness in Psoriatic Arthritis trial achieving minimal disease activity (MDA) and its individual components at 1 or more visits over 144 weeks, identify baseline predictors of MDA achievement, and evaluate the association of MDA status with independent quality of life (QoL)-related patient-reported outcomes (PROs).Univariate and multivariate analyses were used to identify the baseline characteristics that...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 904.0KB)
-
- Publisher copy:
- 10.1136/rmdopen-2016-000415
Authors
Funding
Bibliographic Details
- Publisher:
- BMJ Publishing Group Publisher's website
- Journal:
- RMD Open Journal website
- Volume:
- 3
- Issue:
- 1
- Article number:
- e000415
- Publication date:
- 2017-07-18
- Acceptance date:
- 2017-06-12
- DOI:
- EISSN:
-
2056-5933
- Pmid:
-
29225916
- Source identifiers:
-
1007812
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:1007812
- UUID:
-
uuid:c68a6b99-49c1-4216-8a2c-fc83220c99c5
- Local pid:
- pubs:1007812
- Deposit date:
- 2019-07-01
Terms of use
- Copyright holder:
- Mease et al
- Copyright date:
- 2017
- Notes:
- © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
If you are the owner of this record, you can report an update to it here: Report update to this record